SCHEMBL9908935

SCHEMBL9908935

CC(=O)CCOn1c2ccccc2c2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.47
FABP4 P15090 3/20 0.42
FABP5 Q01469 3/20 0.42
FABP3 P05413 1/20 0.42
KDM4E B2RXH2 3/20 0.41
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
ELANE P08246 3/20 0.40
F2 P00734 1/20 0.40
PLAU P00749 1/20 0.40
HDAC6 Q9UBN7 1/20 0.39
ALDH1A1 P00352 3/20 0.39
TSPO P30536 1/20 0.38
CREBBP Q92793 2/20 0.38
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11491613 0.84 POLB (0.42) POLBFABP4FABP5FABP3KDM4E
SCHEMBL28824473 0.76 GPR3 (0.43) POLBKDM4EELANEF2PLAU
SCHEMBL14421423 0.73 FABP4 (0.70) POLBFABP4FABP5FABP3KDM4E
SCHEMBL1906715 0.72 POLB (0.55) POLBFABP4FABP5FABP3KDM4E
SCHEMBL5746059 0.71 HTR1B (0.45) POLBKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL5747322 0.71 HTR1B (0.45) KDM4EALDH1A1HTT
SCHEMBL27772278 0.71 LMNA (0.50) POLBKDM4EELANEALDH1A1TSPO
SCHEMBL28050685 0.70 FABP4 (0.72) POLBFABP4FABP5FABP3KDM4E
SCHEMBL28546173 0.70 POLB (0.44) POLBFABP4FABP5FABP3KDM4E
SCHEMBL5746680 0.69 HTR1B (0.44) KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150601-B2 Blue-light-emitting iridium complex, iridium complex monomer, phosphorus polymer, and organic electroluminescence device using same GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-10-06 US disclosed
US-9150601-B2 Blue-light-emitting iridium complex, iridium complex monomer, phosphorus polymer, and organic electroluminescence device using same GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-10-06 US disclosed
US-20120138917-A1 BLUE-LIGHT-EMITTING IRIDIUM COMPLEX, IRIDIUM COMPLEX MONOMER, PHOSPHORUS POLYMER, AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120138917-A1 BLUE-LIGHT-EMITTING IRIDIUM COMPLEX, IRIDIUM COMPLEX MONOMER, PHOSPHORUS POLYMER, AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME IPMK, INTS9, ITK POLB 2761/4885FABP4 4043/4885FABP5 3129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.